TLDR: Palantir Technologies and OneMedNet Corporation have announced a multi-year partnership aimed at transforming healthcare AI and Real-World Data (RWD) analytics. This collaboration integrates Palantir’s Artificial Intelligence Platform (AIP) with OneMedNet’s iRWD™ network, providing life sciences and research organizations with access to anonymized, regulatory-grade clinical data and advanced analytics to accelerate medical solutions and tap into the projected $868 billion AI-driven healthcare market by 2030.
DENVER & MINNEAPOLIS – October 16, 2025 – Palantir Technologies Inc. (NASDAQ: PLTR) and OneMedNet Corporation (NASDAQ: ONMD) have officially announced a strategic multi-year partnership designed to revolutionize the landscape of healthcare Artificial Intelligence (AI) and Real-World Data (RWD) analytics. The collaboration, initially announced on October 6, 2025, sees Palantir’s cutting-edge Artificial Intelligence Platform (AIP) integrated with OneMedNet’s expansive iRWD™ near real-time AI-powered provider network.
This powerful synergy is set to empower life sciences, medical device, and research organizations by providing unparalleled access to anonymized, regulatory-grade clinical data and sophisticated analytics. The primary objective is to significantly accelerate the development of innovative medical solutions and streamline clinical research processes.
OneMedNet’s iRWD™ network boasts an impressive reach, offering access to over 5 billion administrative claims and 131 million clinical exams sourced from more than 1,750 provider sites. This vast dataset spans critical areas such as oncology, cardiology, and rare diseases. By leveraging Palantir’s AIP, OneMedNet aims to enhance data discovery, facilitate precise cohort customization, and boost overall productivity through advanced conversational AI and automation capabilities.
Drew Goldstein, Co-Head of Healthcare at Palantir, expressed enthusiasm for the partnership, stating, “We’re proud to provide the AI infrastructure for OneMedNet to accelerate the delivery of transformative healthcare solutions that will ultimately improve patient outcomes.” Aaron Green, President and CEO of OneMedNet, echoed this sentiment, adding, “Palantir’s AIP helps us revolutionize our ability to deliver high-quality, regulatory-compliant data at remarkable speed. This positions us to power breakthroughs in clinical research and AI-driven healthcare solutions.”
The partnership directly addresses a significant barrier in the healthcare sector: access to comprehensive and compliant data. By overcoming this challenge, the companies aim to unlock the immense potential of the AI-driven healthcare market, which is projected to reach an estimated $868 billion by 2030. The integration promises several technological advancements, including faster data discovery, more accurate data delivery, conversational search functionalities, and enhanced productivity through automation, all while maintaining strict adherence to healthcare standards and data privacy regulations through OneMedNet’s proprietary AI algorithms.
Also Read:
- Pacific AI Earns CHAI Certification, Paving Way for Trustworthy Healthcare AI Deployment
- Healthcare and Life Sciences Sectors Embrace AI Agents for Transformative Advancements
For OneMedNet, this collaboration is a strategic move to support market expansion goals and the development of regulatory-grade data cohorts essential for advancements in diagnostics, therapeutics, and personalized medicine. The secure, scalable, and compliant data solutions offered through this partnership are expected to generate scalable recurring revenue opportunities, further solidifying both companies’ positions at the forefront of healthcare innovation.
